Avantis U.S. Equity ETF (AVUS) and Avantis U.S. Small Cap Value ETF (AVUV) come from the same issuer yet follow meaningfully different paths. Both apply Avantis’s systematic tilt toward lower valuations and higher profitability, but they serve separate roles. AVUS acts as a wide-ranging core holding across all market caps, while AVUV narrows in on small-cap value names. Comparing the two helps clarify the trade-off between broad diversification and the higher-return potential, along with higher volatility, of a focused value approach. In the current environment, where large-cap technology continues to lead and interest in cheaper cyclical small caps is resurfacing, the contrast feels particularly relevant.
AVUS aims for long-term capital appreciation through a wide selection of U.S. companies across sectors and sizes. The actively managed fund emphasizes securities that appear undervalued with stronger profitability metrics instead of simply tracking an index. Its roughly 1,900 holdings deliver market-like breadth while preserving a value-and-quality bias.
Leading positions reflect the large-cap emphasis, with NVDA, AAPL, MSFT, AMZN, and META typically at the top, joined by JPM and XOM. Technology accounts for about 29% of the portfolio, followed by financial services at roughly 16%, consumer cyclical and industrials near 11% each, and communication services around 8%. The 0.15% expense ratio remains low, and turnover stays modest through ongoing systematic adjustments.
AVUV seeks long-term appreciation by concentrating on U.S. small-cap companies screened for low valuations and higher profitability. At least 80% of assets stay in small-capitalization names. The actively managed portfolio contains about 800 securities, with the top 10 holdings representing only around 8% of assets, which supports solid diversification inside the small-cap space.
Recent top holdings have included GATX, MATX, SM, FIVE, and ANF. Sector weights tilt toward financials at about 27%, consumer cyclical near 20%, energy around 16%, and industrials at 11%, with technology far less prominent than in AVUS. The 0.25% expense ratio covers a rules-based process that largely avoids unprofitable firms.
Both funds sit amid the ongoing discussion between large-cap growth dominance and a potential shift toward cyclical value. AVUS remains closely linked to mega-cap technology and communication-services performance, where earnings momentum and AI-related spending have shaped recent results. AVUV, meanwhile, responds more to regional-bank health, energy prices, and consumer-discretionary trends.
Macro factors such as interest-rate paths, inflation expectations, and credit conditions affect small caps more strongly because of their higher leverage and domestic revenue exposure. A steady economy and easier policy have historically supported smaller, cheaper stocks, whereas sustained rate pressure or growth concerns can pressure the value segment. Banking-sector regulation and capital flows also represent notable risks for AVUV’s financials-heavy allocation.
Across recent cycles, AVUS has largely followed broad U.S. equity returns, with its value tilt creating only modest deviation from a pure large-cap growth benchmark. Technology exposure has helped during growth rallies, while energy and financials weightings have provided some buffer in value rotations.
AVUV has shown noticeably higher volatility and a clearer small-cap value factor profile. It has performed well when investors favored cheaper, cyclical stocks but lagged during mega-cap growth stretches. Valuation spreads between small-cap value and large-cap growth remain wide by historical standards, which supports the case for mean reversion, though that potential comes with larger drawdowns and greater sensitivity to economic and credit conditions.
I also checked this using Tickeron’s AI Screener to compare factor exposures and sector tilts across similar ETFs. The tool allowed me to quickly filter for valuation metrics, volatility profiles, and performance patterns, confirming the structural differences between the two funds in a single scan. It has become a regular part of how I evaluate relative positioning before making allocation decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for AVUS crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVUS as a result. In 55 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for AVUS turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 39 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
AVUS moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for AVUS entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +2.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVUS advanced for three days, in 272 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
AVUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows